QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
QQQ   309.75 (+1.19%)
AAPL   158.93 (+0.70%)
MSFT   277.66 (+1.97%)
META   204.28 (+2.24%)
GOOGL   105.60 (+2.16%)
AMZN   98.71 (+0.01%)
TSLA   192.22 (+0.56%)
NVDA   271.91 (+2.73%)
NIO   9.27 (+1.98%)
BABA   86.52 (+3.43%)
AMD   100.28 (+2.77%)
T   18.46 (+0.38%)
F   11.42 (-0.52%)
MU   61.34 (+5.45%)
CGC   1.91 (+1.60%)
GE   91.59 (+2.23%)
DIS   95.83 (+0.98%)
AMC   4.47 (+3.00%)
PFE   40.18 (+0.42%)
PYPL   72.56 (-2.39%)
NFLX   320.37 (+9.01%)
NASDAQ:FLGT

Fulgent Genetics - FLGT Stock Forecast, Price & News

$30.15
-0.14 (-0.46%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$30.00
$31.39
50-Day Range
$30.15
$36.27
52-Week Range
$28.53
$65.32
Volume
151,348 shs
Average Volume
239,296 shs
Market Capitalization
$890.00 million
P/E Ratio
6.61
Dividend Yield
N/A
Price Target
$41.67

Fulgent Genetics MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
38.2% Upside
$41.67 Price Target
Short Interest
Healthy
4.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.25) to ($1.53) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.65 out of 5 stars

Medical Sector

85th out of 986 stocks

Medical Laboratories Industry

5th out of 26 stocks


FLGT stock logo

About Fulgent Genetics (NASDAQ:FLGT) Stock

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in Temple City, CA.

Receive FLGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter.

FLGT Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Fulgent Genetics, Inc. (FLGT)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Q4 2022 Fulgent Genetics Inc Earnings Call
This Medical Play Is Up to the Test
My Top 7 Strong Conviction Buys for 2023
At EV/Sales Below 1x, Fulgent Is Undervalued
Where Fulgent Genetics Stands With Analysts
See More Headlines
Receive FLGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter.

FLGT Company Calendar

Last Earnings
2/28/2023
Today
3/23/2023
Next Earnings (Estimated)
5/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FLGT
Employees
1,012
Year Founded
2011

Price Target and Rating

Average Stock Price Forecast
$41.67
High Stock Price Forecast
$45.00
Low Stock Price Forecast
$35.00
Forecasted Upside/Downside
+38.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$143.40 million
Pretax Margin
29.73%

Debt

Sales & Book Value

Annual Sales
$618.97 million
Cash Flow
$6.39 per share
Book Value
$43.14 per share

Miscellaneous

Free Float
20,811,000
Market Cap
$890.00 million
Optionable
Not Optionable
Beta
1.61

Social Links


Key Executives

  • Ming HsiehMing Hsieh
    Chairman & Chief Executive Officer
  • James Xie
    President & Chief Operating Officer
  • Paul H. KimPaul H. Kim
    Chief Financial Officer
  • Harry Gao
    Chief Scientific Officer & Laboratory Director
  • Lawrence M. Weiss
    Chief Medical Officer













FLGT Stock - Frequently Asked Questions

Should I buy or sell Fulgent Genetics stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FLGT shares.
View FLGT analyst ratings
or view top-rated stocks.

What is Fulgent Genetics' stock price forecast for 2023?

3 brokers have issued 1-year target prices for Fulgent Genetics' shares. Their FLGT share price forecasts range from $35.00 to $45.00. On average, they anticipate the company's share price to reach $41.67 in the next twelve months. This suggests a possible upside of 38.2% from the stock's current price.
View analysts price targets for FLGT
or view top-rated stocks among Wall Street analysts.

How have FLGT shares performed in 2023?

Fulgent Genetics' stock was trading at $29.78 at the start of the year. Since then, FLGT stock has increased by 1.2% and is now trading at $30.15.
View the best growth stocks for 2023 here
.

Are investors shorting Fulgent Genetics?

Fulgent Genetics saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 908,500 shares, an increase of 5.9% from the February 13th total of 857,800 shares. Based on an average trading volume of 239,200 shares, the short-interest ratio is currently 3.8 days. Currently, 4.9% of the company's shares are short sold.
View Fulgent Genetics' Short Interest
.

When is Fulgent Genetics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our FLGT earnings forecast
.

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics, Inc. (NASDAQ:FLGT) posted its quarterly earnings data on Tuesday, February, 28th. The company reported ($0.71) EPS for the quarter, topping analysts' consensus estimates of ($0.78) by $0.07. The company earned $67.70 million during the quarter, compared to analysts' expectations of $59.44 million. Fulgent Genetics had a trailing twelve-month return on equity of 11.93% and a net margin of 23.17%.

What guidance has Fulgent Genetics issued on next quarter's earnings?

Fulgent Genetics updated its first quarter 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $56.00 million-$56.00 million, compared to the consensus revenue estimate of $60.92 million.

What other stocks do shareholders of Fulgent Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Block (SQ), JD.com (JD), Marvell Technology (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT).

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

Who are Fulgent Genetics' major shareholders?

Fulgent Genetics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (2.71%), Pacer Advisors Inc. (1.98%), Geode Capital Management LLC (1.34%), JPMorgan Chase & Co. (1.15%), Morgan Stanley (0.90%) and American Century Companies Inc. (0.81%). Insiders that own company stock include Hanlin Gao, Jian Xie, John C Bolger, Paul Kim and X Cycle LP Tcv.
View institutional ownership trends
.

How do I buy shares of Fulgent Genetics?

Shares of FLGT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $30.15.

How much money does Fulgent Genetics make?

Fulgent Genetics (NASDAQ:FLGT) has a market capitalization of $890.00 million and generates $618.97 million in revenue each year. The company earns $143.40 million in net income (profit) each year or $4.56 on an earnings per share basis.

How many employees does Fulgent Genetics have?

The company employs 1,012 workers across the globe.

Does Fulgent Genetics have any subsidiaries?
The following companies are subsidiares of Fulgent Genetics: CSI, Cytometry Specialists Inc., FF Gene Biotech, Fulgent Investment Development Limited, Fulgent Therapeutics LLC, and Inform Diagnostics.
Read More
How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The official website for the company is www.fulgentgenetics.com. The company can be reached via phone at (626) 350-0537, via email at nborsje@blueshirtgroup.com, or via fax at 626-454-1667.

This page (NASDAQ:FLGT) was last updated on 3/23/2023 by MarketBeat.com Staff